Enhanced production of squalene in the thraustochytrid Aurantiochytrium mangrovei by medium optimization and treatment with terbinafine
- 997 Downloads
Squalene is an effective chemopreventive agent in reducing the incident of coronary heart disease and cancer. It is also a strong antioxidant used extensively in the food and cosmetic industries. Microbial sources of squalene are being explored in recent years. The objective of this study is to increase the squalene content and yield in the thraustochytrid, Aurantiochytrium mangrovei FB3 through medium optimization and the treatment with terbinafine, an inhibitor of squalene monooxygenase in the sterol biosynthetic pathway. The highest biomass concentration of 21.2 g l−1 was obtained at a glucose concentration of 60 g l−1, while the highest specific growth rate of 0.077 h−1 and the growth yield coefficient of 0.44 g g−1 based on glucose were achieved at a lower glucose concentration (30 g l−1). The addition of terbinafine led to a slight inhibition of cell growth whereas an obvious increase in squalene content was observed at terbinafine concentrations of 10 and 100 mg l−1, which corresponded to an increase of 36 and 40% in squalene content, respectively compared to the control. The addition of terbinafine was thus effective in inducing the accumulation of squalene in A. mangrovei. This study not only demonstrated the production potential of squalene by A. mangrovei, but also provided novel information on the accumulation effect of terbinafine on the biosynthesis of an essential intermediate involved in sterol metabolic pathway.
KeywordsMicroalga Aurantiochytrium mangrovei Squalene Terbinafine
This research was supported by the RGC (Research Grants Council of Hong Kong).
- Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917Google Scholar
- Chan P, Tomlinson B, Lee CB, Lee YS (1996) Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia. J Clin Pharmacol 36:422–427Google Scholar
- Kelly GS (1999) Squalene and its clinical uses. Altern med Rev 4:29–36Google Scholar
- Kohno Y, Egawa Y, Itoh S, Nagaoka S, Takahashi M, Mukai K (1995) Kinetic study of quenching reaction of singlet oxygen and scavenging reaction of free radical by squalene in n-butanol. Biochim Biophys Acta 1256:52–56Google Scholar
- Lu HT, Jiang Y, Chen F (2004) Determination of squalene using high-performance liquid chromatography with diode array detection. Chromatographia 59:367–371Google Scholar
- Newmark HL (1999) Squalene, olive oil and cancer—review and hypothesis. Cancer Epidemiol Biomarkers Prev 889:193–203Google Scholar
- Ryder NS (1990) Inhibition of squalene epoxidase and sterol side-chain methylation by allylamines. Biochem Soc Trans 18:45–46Google Scholar
- Valero E, Millán C, Ortega JM (2002) Changes in the lipid composition of Saccharomyces cerevisiae race Capensis (G-1) during alcoholic fermentation and flor film formation. Food Sc Technol 35:593–599Google Scholar
- Yokoyama R, Honda D (2007) Taxonomic rearrangement of the genus Schizochytrium sensu lato on morphology, chemotaxonomic characteristics, and 18S rRNA gene phylogeny (Thraustochytriaceae, Labyrinthulomycetes): emendation for Schizochytrium and erection of Aurantiochytrium and Oblongichytrium gen. nov. Mycoscience 48:199–211CrossRefGoogle Scholar